Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Parthun

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Genes & Development|May 20, 2014
Hat2p recognizes the histone H3 tail to specify the acetylation of the newly synthesized H3/H4 heterodimer by the Hat1p/Hat2p complexYang Li, Li Zhang, Tingting Liu, et al.
Blood|March 22, 2003
Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP proteinJennifer L Aron, Mark R Parthun, Guido Marcucci, et al.
Proteomics|March 3, 2009
Validation of an LC-MS based approach for profiling histones in chronic lymphocytic leukemiaXiaodan Su, David M Lucas, Liwen Zhang, et al.
Journal of Neuromuscular Diseases|November 19, 2016
Spinal Muscular Atrophy Biomarker Measurements from Blood Samples in a Clinical Trial of Valproic Acid in Ambulatory AdultsSamantha R Renusch, Sean Harshman, Hongyang Pi, et al.
Blood|October 7, 2004
A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemiaJohn C Byrd, Guido Marcucci, Mark R Parthun, et al.
Plos One|June 10, 2010
The novel deacetylase inhibitor AR-42 demonstrates pre-clinical activity in B-cell malignancies in vitro and in vivoDavid M Lucas, Lapo Alinari, Derek A West, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Genes & Development|May 20, 2014
Hat2p recognizes the histone H3 tail to specify the acetylation of the newly synthesized H3/H4 heterodimer by the Hat1p/Hat2p complexYang Li, Li Zhang, Tingting Liu, et al.
Blood|March 22, 2003
Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP proteinJennifer L Aron, Mark R Parthun, Guido Marcucci, et al.
Proteomics|March 3, 2009
Validation of an LC-MS based approach for profiling histones in chronic lymphocytic leukemiaXiaodan Su, David M Lucas, Liwen Zhang, et al.
Journal of Neuromuscular Diseases|November 19, 2016
Spinal Muscular Atrophy Biomarker Measurements from Blood Samples in a Clinical Trial of Valproic Acid in Ambulatory AdultsSamantha R Renusch, Sean Harshman, Hongyang Pi, et al.
Blood|October 7, 2004
A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemiaJohn C Byrd, Guido Marcucci, Mark R Parthun, et al.
Plos One|June 10, 2010
The novel deacetylase inhibitor AR-42 demonstrates pre-clinical activity in B-cell malignancies in vitro and in vivoDavid M Lucas, Lapo Alinari, Derek A West, et al.
Pageof 6